Filing Details

Accession Number:
0001127602-20-008270
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-02-28 10:28:14
Reporting Period:
2020-02-27
Accepted Time:
2020-02-28 10:28:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1100682 Charles River Laboratories International Inc. CRL Services-Commercial Physical & Biological Research (8731) 061397316
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1144771 D Stephen Chubb 251 Ballardvale Street
Wilmington MA 01887
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-02-27 4,030 $43.39 38,865 No 4 M Direct
Common Stock Acquisiton 2020-02-27 3,140 $70.29 42,005 No 4 M Direct
Common Stock Disposition 2020-02-27 2,464 $160.89 39,541 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options (Right to Buy) Disposition 2020-02-27 4,030 $0.00 4,030 $43.39
Common Stock Stock Options (Right to Buy) Disposition 2020-02-27 3,140 $0.00 3,140 $70.29
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2014-05-08 2020-05-08 No 4 M Direct
0 2016-05-06 2020-05-06 No 4 M Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $160.84 to $160.93 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.